Improved in vitro function of islets using small intestinal submucosa

E. J. Woods, C. M. Walsh, R. A. Sidner, M. A J Zieger, J. R T Lakey, Camillo Ricordi, J. K. Critser

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Transplantation of human pancreatic islets has been demonstrated to be a viable alternative to exogenous insulin therapy for diabetes mellitus. However, optimum results require transplantation of islets from two to three pancreas donors after a minimum number of days in culture. This implies that a substantial part of the transplanted islet mass may be nonfunctional. This study investigates the ability of an optimized technique to retain islet function using porcine-derived small intestinal submucosa (SIS) during in vitro culture. Groups of purified human islets were cultured for 3 weeks in modified standard islet culture conditions of CMRL = 1066 tissue culture medium supplemented with 25 mmol/L HEPES, penicillin/streptomycin, and a commercial insulin-transferin- selenium (ITS) supplement. Islets (50 to 200 IE/condition; n = 5 preparations) were cultured in plates containing noncoated Biopore membrane inserts alone, or on inserts that had been covered with SIS. Function was assessed by static incubation with low (4 mmol/L), or high (20 mmol/L) glucose at the end of each week. Glucose-stimulated release of human insulin was measured by radioimmunoassay (Linco, St. Charles, Missouri). Remaining islets were stained and evaluated visually. Neither culture condition resulted in significantly different basal secretion until week 3 (P = .05). However, by the end of week 2 and for the duration of the experiment thereafter, SIS-treated islets exhibited a higher SI (P < .05). At the end of the experiment, islets cultured on the SIS exhibited excellent morphology, with greater than 90% staining positive with Dithizone. Islets cultured on the inserts alone lost their initial morphology, becoming "loose" in appearance. The results of this study indicate that SIS enables enhanced function of islets in vitro as compared to non-SIS supported culture conditions.

Original languageEnglish
Pages (from-to)1175-1177
Number of pages3
JournalTransplantation Proceedings
Volume36
Issue number4
DOIs
StatePublished - May 1 2004

Fingerprint

Islets of Langerhans Transplantation
Insulin
Dithizone
HEPES
Glucose
Streptomycin
Selenium
Penicillins
Radioimmunoassay
Culture Media
Pancreas
Diabetes Mellitus
Swine
Staining and Labeling
Membranes
In Vitro Techniques
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Woods, E. J., Walsh, C. M., Sidner, R. A., Zieger, M. A. J., Lakey, J. R. T., Ricordi, C., & Critser, J. K. (2004). Improved in vitro function of islets using small intestinal submucosa. Transplantation Proceedings, 36(4), 1175-1177. https://doi.org/10.1016/j.transproceed.2004.04.042

Improved in vitro function of islets using small intestinal submucosa. / Woods, E. J.; Walsh, C. M.; Sidner, R. A.; Zieger, M. A J; Lakey, J. R T; Ricordi, Camillo; Critser, J. K.

In: Transplantation Proceedings, Vol. 36, No. 4, 01.05.2004, p. 1175-1177.

Research output: Contribution to journalArticle

Woods, EJ, Walsh, CM, Sidner, RA, Zieger, MAJ, Lakey, JRT, Ricordi, C & Critser, JK 2004, 'Improved in vitro function of islets using small intestinal submucosa', Transplantation Proceedings, vol. 36, no. 4, pp. 1175-1177. https://doi.org/10.1016/j.transproceed.2004.04.042
Woods, E. J. ; Walsh, C. M. ; Sidner, R. A. ; Zieger, M. A J ; Lakey, J. R T ; Ricordi, Camillo ; Critser, J. K. / Improved in vitro function of islets using small intestinal submucosa. In: Transplantation Proceedings. 2004 ; Vol. 36, No. 4. pp. 1175-1177.
@article{dcd89ec8b208413495ef04e0a0f18206,
title = "Improved in vitro function of islets using small intestinal submucosa",
abstract = "Transplantation of human pancreatic islets has been demonstrated to be a viable alternative to exogenous insulin therapy for diabetes mellitus. However, optimum results require transplantation of islets from two to three pancreas donors after a minimum number of days in culture. This implies that a substantial part of the transplanted islet mass may be nonfunctional. This study investigates the ability of an optimized technique to retain islet function using porcine-derived small intestinal submucosa (SIS) during in vitro culture. Groups of purified human islets were cultured for 3 weeks in modified standard islet culture conditions of CMRL = 1066 tissue culture medium supplemented with 25 mmol/L HEPES, penicillin/streptomycin, and a commercial insulin-transferin- selenium (ITS) supplement. Islets (50 to 200 IE/condition; n = 5 preparations) were cultured in plates containing noncoated Biopore membrane inserts alone, or on inserts that had been covered with SIS. Function was assessed by static incubation with low (4 mmol/L), or high (20 mmol/L) glucose at the end of each week. Glucose-stimulated release of human insulin was measured by radioimmunoassay (Linco, St. Charles, Missouri). Remaining islets were stained and evaluated visually. Neither culture condition resulted in significantly different basal secretion until week 3 (P = .05). However, by the end of week 2 and for the duration of the experiment thereafter, SIS-treated islets exhibited a higher SI (P < .05). At the end of the experiment, islets cultured on the SIS exhibited excellent morphology, with greater than 90{\%} staining positive with Dithizone. Islets cultured on the inserts alone lost their initial morphology, becoming {"}loose{"} in appearance. The results of this study indicate that SIS enables enhanced function of islets in vitro as compared to non-SIS supported culture conditions.",
author = "Woods, {E. J.} and Walsh, {C. M.} and Sidner, {R. A.} and Zieger, {M. A J} and Lakey, {J. R T} and Camillo Ricordi and Critser, {J. K.}",
year = "2004",
month = "5",
day = "1",
doi = "10.1016/j.transproceed.2004.04.042",
language = "English",
volume = "36",
pages = "1175--1177",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Improved in vitro function of islets using small intestinal submucosa

AU - Woods, E. J.

AU - Walsh, C. M.

AU - Sidner, R. A.

AU - Zieger, M. A J

AU - Lakey, J. R T

AU - Ricordi, Camillo

AU - Critser, J. K.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Transplantation of human pancreatic islets has been demonstrated to be a viable alternative to exogenous insulin therapy for diabetes mellitus. However, optimum results require transplantation of islets from two to three pancreas donors after a minimum number of days in culture. This implies that a substantial part of the transplanted islet mass may be nonfunctional. This study investigates the ability of an optimized technique to retain islet function using porcine-derived small intestinal submucosa (SIS) during in vitro culture. Groups of purified human islets were cultured for 3 weeks in modified standard islet culture conditions of CMRL = 1066 tissue culture medium supplemented with 25 mmol/L HEPES, penicillin/streptomycin, and a commercial insulin-transferin- selenium (ITS) supplement. Islets (50 to 200 IE/condition; n = 5 preparations) were cultured in plates containing noncoated Biopore membrane inserts alone, or on inserts that had been covered with SIS. Function was assessed by static incubation with low (4 mmol/L), or high (20 mmol/L) glucose at the end of each week. Glucose-stimulated release of human insulin was measured by radioimmunoassay (Linco, St. Charles, Missouri). Remaining islets were stained and evaluated visually. Neither culture condition resulted in significantly different basal secretion until week 3 (P = .05). However, by the end of week 2 and for the duration of the experiment thereafter, SIS-treated islets exhibited a higher SI (P < .05). At the end of the experiment, islets cultured on the SIS exhibited excellent morphology, with greater than 90% staining positive with Dithizone. Islets cultured on the inserts alone lost their initial morphology, becoming "loose" in appearance. The results of this study indicate that SIS enables enhanced function of islets in vitro as compared to non-SIS supported culture conditions.

AB - Transplantation of human pancreatic islets has been demonstrated to be a viable alternative to exogenous insulin therapy for diabetes mellitus. However, optimum results require transplantation of islets from two to three pancreas donors after a minimum number of days in culture. This implies that a substantial part of the transplanted islet mass may be nonfunctional. This study investigates the ability of an optimized technique to retain islet function using porcine-derived small intestinal submucosa (SIS) during in vitro culture. Groups of purified human islets were cultured for 3 weeks in modified standard islet culture conditions of CMRL = 1066 tissue culture medium supplemented with 25 mmol/L HEPES, penicillin/streptomycin, and a commercial insulin-transferin- selenium (ITS) supplement. Islets (50 to 200 IE/condition; n = 5 preparations) were cultured in plates containing noncoated Biopore membrane inserts alone, or on inserts that had been covered with SIS. Function was assessed by static incubation with low (4 mmol/L), or high (20 mmol/L) glucose at the end of each week. Glucose-stimulated release of human insulin was measured by radioimmunoassay (Linco, St. Charles, Missouri). Remaining islets were stained and evaluated visually. Neither culture condition resulted in significantly different basal secretion until week 3 (P = .05). However, by the end of week 2 and for the duration of the experiment thereafter, SIS-treated islets exhibited a higher SI (P < .05). At the end of the experiment, islets cultured on the SIS exhibited excellent morphology, with greater than 90% staining positive with Dithizone. Islets cultured on the inserts alone lost their initial morphology, becoming "loose" in appearance. The results of this study indicate that SIS enables enhanced function of islets in vitro as compared to non-SIS supported culture conditions.

UR - http://www.scopus.com/inward/record.url?scp=2942655455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942655455&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2004.04.042

DO - 10.1016/j.transproceed.2004.04.042

M3 - Article

C2 - 15194407

AN - SCOPUS:2942655455

VL - 36

SP - 1175

EP - 1177

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 4

ER -